Ipsen
Ipsen

Ipsen’s $18bn Pipeline Expansion Targets Movement Disorders
BIOT
🔬 Ipsen SA and Skyhawk Therapeutics Inc join forces in a groundbreaking $1.8bn deal to treat rare neurological disorders. 💪🧠
Ipsen

🔬 Ipsen SA and Skyhawk Therapeutics Inc join forces in a groundbreaking $1.8bn deal to treat rare neurological disorders. 💪🧠